Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a…
June 05, 2026 19:30 ET | Source: Oban BioPharma, Inc. STAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma…
Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target…
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of…
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older…
Shenzhen, June 05, 2026 (GLOBE NEWSWIRE) -- SHARE3DCAM, a developer of professional SLAM LiDAR scanning solutions, today announced the release…
Houston, Texas, USA, June 05, 2026 (GLOBE NEWSWIRE) -- I. Hybrid Work Fuels Rising Multi-Monitor Demand The growing prevalence of…
Kwun Tong, Kowloon, HK, June 05, 2026 (GLOBE NEWSWIRE) -- The newly registered 56-day exploratory study of NatureU® Mind Care…
Publication presented concurrently with oral presentation at American Diabetes Association’s 86th Scientific Sessions from ACCESS development program with aleniglipron, a…
June 05, 2026 16:05 ET | Source: Shattuck Labs, Inc. AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE)…